The EUropean Federation for Exploratory MEdicines Development (EUFEMED

Frights create a happy Halloween by providing the thrill of fear in a controlled and safe environment, turning what.

MID‐Frail News returns with this Special Issue to report on the project development

Read the latest newsletter here [1]. In this edition

Our group of academic and industry partners won a big MRC grant yesterday

In this case the plan is a paradigm shift in the way we will manage

In its recent white paper on severe asthma, The Severe Asthma Report 2017

Investigator sites are very important to clinical studies because they make sure that new drugs are safe and work well.

Our publication on sarcoidosis, a multisystem inflammatory disease

Last night saw a collection of the UK’s great and the good in clinical pharmacology

Welcome to the latest issue of the Refractory Asthma Stratification Programme (RASP-UK)

The New Year started excellently for MID-Frail with the first patients

The latest issue of Journal Frontiers in Pharmacology has just published

As a jobbing scientist you rarely spend your whole career working on the same project.

Welcome to the first issue of the MID‐Frail newsletter

However you may feel about the way political leaders have turned Brexit

Many scientists believe that we have reached the end of the life-expectancy revolution

2012 has been a very busy year for the MID-Frail partners and the study consortium

Phenotype-specific omic expression patterns in people with frailty could provid

Our publication on new therapies in the management of type 2 diabetes mellitus

If you have been involved in the pharmaceutical industry for any length

If you're managing a project, it's important to stay informed about work progress

The clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer,

It was encouraging to see so many partners at the 2017 General Assembly meeting last December

Welcome to the second issue of the Refractory Asthma Stratification

Experience at Niche has taught us that clinical study protocols are born in the white-hot fire

All of our core studies have now completed their clinical phase

Whether it’s a festival, concert or celebratory party, music unites people and pervades

The world's first human COVID challenge trial has been given the green light

We've been sharing you our Insider's Insights with you for 2 years now.

The US Army has a new secret weapon – napping.

Niche Science & Technology Ltd. are leading the team today awarded a Euro 7.5M

There have been hundreds of thousands of deaths from COVID-19

Rational Vaccines (RVx) announces MHRA Innovation Licensing and Access Pathway (ILAP) approval for their live attenuated.

We are looking over the precipice that is a revolution in lifespan modification.

Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the.

This essential reading provides readers with a round-up of news on the latest events

High functioning investigator sites are essential to the delivery

The largest pharmaceutical companies not surprisingly rely on the largest contract research organizations

In the UK we have a saying that you wait hours for a bus and then two come along at once.

Unfortunately, health does not generally improve with age.

May 4 is often known as ‘Star Wars Day’. It is jokingly said

The UK's world-class human challenge study gives us new information about SARS-CoV-2 cases that were mild in 36 healthy.

Every year, a huge amount of scientific data is released. It's out there, but how do you find it?

Investigator-Initiated Clinical Trials (IITs) are clinical studies led by academic researchers or clinicians

Our publication on effectiveness of a multimodal intervention

Frailty has a dramatic impact on the quality of life of many elderly people

With age comes wisdom, however the physical side of ageing

Do you know what Good Laboratory Practice stands for? In nonclinical animal studies

We all have a responsibility to encourage young people to study science

Having worked in early-stage clinical pharmacology for over 30 years

Metathesiophobia: from Preclinical to Clinical Development

Asthma is a chronic inflammatory disorder of the airways

Ask anyone and they will tell you that they don’t think they are as old as they are.

Metathesiophobia: from Preclinical to Clinical Development

Phase I is the lifeblood or new medicines. The UK’s Phase I representative body,

The world's first human COVID challenge trial has been given the green light

According to many observers we are standing on the precipice

I am shamelessly referencing our Insider’s Insights (IIs) to Dr Who’s TARDIS – our latest edition

Have you seen our latest Insider's Insight on Case Reports? Once a staple of medical journals,

Advisory board meetings are often used to address perceived knowledge gaps and build consensus.

You can now download our latest newsletter, detailing how 2014

Clinical trials are not cheap to conduct, and with data integrity

In 1786, estimates placed our average life expectancy at just 24 years.

Deep Breath is the official newsletter of the UKs Refactory Asthma

Read the latest newsletter from both our MID-Frail

Attend any research meeting, conference or clinical congress

Here are a few lists of the best of the best over the last 12 months.

The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)

We are looking over the precipice that is a revolution

Many of the increasing number of elderly in our population

When I was younger, the opening lines of the Beatle’s seminal ‘Sgt. Pepper’s Lonely Hearts Club Band’ resonated.

Early in 2020, COVID-19 was spreading rapidly across the globe.

Download the third issue of the Refractory Asthma Stratification

The world's first human COVID challenge trial has been given the green light